Amniotic Fluid Stem Cells Inhibit the Progression of Bleomycin-Induced Pulmonary Fibrosis via CCL2 Modulation in Bronchoalveolar Lavage

The potential for amniotic fluid stem cell (AFSC) treatment to inhibit the progression of fibrotic lung injury has not been described. We have previously demonstrated that AFSC can attenuate both acute and chronic-fibrotic kidney injury through modification of the cytokine environment. Fibrotic lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Orquidea, Carraro, Gianni, Turcatel, Gianluca, Hall, Marisa, Sedrakyan, Sargis, Roche, Tyler, Buckley, Sue, Driscoll, Barbara, Perin, Laura, Warburton, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742516/
https://www.ncbi.nlm.nih.gov/pubmed/23967234
http://dx.doi.org/10.1371/journal.pone.0071679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742516/
https://www.ncbi.nlm.nih.gov/pubmed/23967234
http://dx.doi.org/10.1371/journal.pone.0071679

Ejemplares similares